Natixis’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$1.64M Buy
2024
Q3
$1.26M Buy
2024
Q2
$73.6K Sell
2024
Q1
$77K Buy
2023
Q2
Sell
2023
Q1
$241K Sell
2022
Q4
$13.9M Sell
2022
Q3
$15.2M Sell
2022
Q2
$13.4M Buy
2022
Q1
$10.5M Sell
2021
Q4
$21.4M Buy
2021
Q2
Sell
2021
Q1
$409K Sell
2020
Q4
$28.4M Buy
2019
Q1
Sell
2018
Q4
$4.34M Buy
2018
Q3
$2.19M Buy
2018
Q2
$576K Sell
2018
Q1
$564K Sell
2017
Q4
$754K Buy